Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Editorial Volume 5 Issue 12

Drug Repurposing: An Emerging Tool to Accelerate the Drug Development Process

Shafina Siddiqui1, Shine Devarajan1, Soumya Basu2 and Jyotirmoi Aich1*

1School of Biotechnology and Bioinformatics, DY Patil Deemed to Be University, CBD Belapur, Maharashtra, India
2Cancer and Translational Research Laboratory, Dr. D.Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Maharashtra, India

*Corresponding Author: Jyotirmoi Aich, School of Biotechnology and Bioinformatics, DY Patil Deemed to Be University, CBD Belapur, Maharashtra, India.

Received: September 07, 2021; Published: November 01, 2021

×

Abstract

Science and technology has greatly advanced in the past few years, and is progressing at an unmatched rate. With the several advancements, it has brought a lot of ease to the overall drug discovery and development method. It is known that the de novo development of drug is an extremely time-consuming and expensive process. Therefore, in order to find its potential alternative, ‘Drug Repurposing’ has come into practice for many years. Drug Repurposing has been considered as a revolutionary breakthrough in accelerating the process of drug development process. It involves seeking new indications of drugs that already been approved by Food and Drug Administration, thereby substantial reduction of cost and time. Ever-increasing molecular, genomic and pharmacological data has further contributed in the success of drug repurposing approaches. This editorial outlines the different tools used in Drug Repurposing

Keywords: Drug Repurposing; In-silico Methods; Genomics; High-Throughput Sequencing Technologies; Literature Mining

×

References

  1. Brogi Simone. "Editorial: In silico Methods for Drug Design and Discovery”. Frontiers in Chemistry (2020): 1-5.
  2. Swamidass S., et al. "Computational approaches to drug repurposing and pharmacology”. Pacific Symposium on Biocomputing (2014): 110-113.
  3. March-Vila., et al. "On the integration of in silico drug design methods for drug repurposing”. Frontiers in Pharmacology (2017): 1-7.
  4. Hodos Rachel A., et al. "In silico methods for drug repurposing and pharmacology”. Wiley Interdisciplinary Reviews: Systems Biology and Medicine15 (2016): 186-210.
  5. Tejera Eduardo Munteanu., et al. "Molecular Dynamics for Possible Inhibitors of Molecules”. (2020): 51-72.
  6. Ibrahim Mahmoud AA., et al. "In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors”. Journal of Biomolecular Structure and Dynamics (2020): 1-12.
  7. Nabirotchkin Serguei Peluffo., et al. "Next-generation drug repurposing using human genetics and network biology”. Current Opinion in Pharmacology (2020): 78-92.
  8. Spreafico Roberto Soriaga., et al. "Advances in genomics for drug development”. Genes (2020): 1-19.
  9. Pritchard Jayne Louise E., et al. "Enhancing the promise of drug repositioning through genetics”. Frontiers in Pharmacology 8 (2017): 1-9.
  10. Cheng Feixiong Lu., et al. "A genome-wide positioning systems network algorithm for in silico drug repurposing”. Nature Communications (2019).
  11. JP Hughes., et al. "Principles of early drug”. British Journal of Pharmacology (2011): 239-1249.
  12. Ryan P Trombetta., et al. "A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants”. mSphere (2018): 1-13.
  13. Blucher Aurora S., et al. "Challenges in secondary analysis of high throughput screening data”. Pacific Symposium on Biocomputing (2014): 114-124.
  14. Naiem T Issa., et al. "Repurpose VS: A Drug Repurposing-Focused Computational Method for Accurate Drug-Target Signature Predictions”. Combinatorial Chemistry and High Throughput Screening8 (2015): 784-794.
  15. Leonardo G Ferreira., et al. "Molecular Docking and Structure-Based Drug Design Strategies”. Molecules 7 (2015): 13384-13421.
  16. Piotr Przybyła., et al. "Text mining resources for the life sciences”. Database 25 (2016): 1-30.
  17. Hsih-Te Yang., et al. "Literature-based discovery of new candidates for drug repurposing”. Briefings in Bioinformatics (2017): 488-497.
  18. Jarada Tamer N., et al. "A review of computational drug repositioning: Strategies, approaches, opportunities, challenges, and directions”. Journal of Cheminformatics 12 (2020): 1-23.
  19. Jiao Li., et al. "Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts”. PLoS Computational Biology7 (2009).
  20. Christos Andronis., et al. "Literature mining, ontologies and information visualization for drug repurposing”. Briefings in Bioinformatics4 (2011): 357-368.
  21. Dmitry Tworowski., et al. "COVID19 Drug Repository: Text-mining the literature in search of putative COVID19 therapeutics”. Nucleic Acids Research1 (2021): D1113-D1121.
×

Citation

Citation: Jyotirmoi Aich., et al. “Drug Repurposing: An Emerging Tool to Accelerate the Drug Development Process”. Acta Scientific Cancer Biology 5.12 (2021): 01-04.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is November 30, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US